treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution

RxCUI: 857795
RxNorm name: treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution
Display name: treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution
Full name: treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TYVASO	TREPROSTINIL	United Therapeutics Corporation	cbc31ab1-a80f-4b50-a3b1-39910b0fb609	2026-04-14	Warnings, Adverse reactions	Exact identifier rxcui: 857795

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
cbc31ab1-a80f-4b50-a3b1-39910b0fb609	treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution [PSN] · treprostinil 0.6 MG/ML Inhalation Solution [SCD] · treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution [SY]	3	32	These highlights do not include all the information needed to use TYVASO safely and effectively. See full prescribing information for TYVASO. TYVASO ® (treprostinil) inhalation solution, for oral inhalation use Initial U.S. Approval: 2002	20260414